Integration of pharmacogenomics into precision medicine: transforming healthcare for the next generation

Read full text
Authors: Umair Ali, Raghabendra Kumar Mahato
Cited by: 1
References: 4

Abstract

Pharmacogenomics is now an essential part of precision medicine, as it describes how genetic differences at the individual level influence drug responses. Its combination enables a transition from trial-and-error prescriptions to predictive, genotype-directed treatment, thereby enhancing the safety and accuracy of treatment. Rapid genomic testing, AI-driven prediction of drug-gene interactions, and clinical decision-support systems have advanced, increasing their uptake in psychiatry, cardiology, and oncology. New methods, such as polygenic pharmacogenomic scoring and population-specific genomic maps, are even more personalized. Together, these advances make pharmacogenomics a central figure with the potential to shape the future of personalized, effective, and innovative healthcare.

Fields of Study & Subjects

Pharmacogenetics and Drug Metabolism Genetic Associations and Epidemiology Genomics and Rare Diseases

Publication details

Journal / source
Annals of Medicine and Surgery
Publisher
Ovid Technologies (Wolters Kluwer Health)
Volume
88
Issue
2
Pages
2192–2193
Publication date
21 January 2026
Language
EN